Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cancer Manag Res ; 11: 4327-4333, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31190997

RESUMO

Purpose: To investigate the prevention effect of low-temperature atomization inhalation for radiation induced oral mucositis (OM) in patients with head and neck cancer (HNC) undergoing radiotherapy. Patients and methods: A total of 68 patients with HNC (including nasopharyngeal cancer) undergoing radiotherapy were divided into an intervention group (33 cases) and a control group (35 cases). During radiotherapy, the intervention group received low-temperature (between 4°C and 8°C) atomization inhalation; while the control group received normal temperature (between 18°C and 24°C) atomization inhalation. Atomization inhalation was performed twice a day, 20 minutes per time, using distilled water. The incidence and severity of OM was evaluated every week during radiotherapy. The comparation was made between the two groups. Results: The two groups were comparable among age, sex, Eastern Cooperative Oncology group (ECOG) score, body mass index (BMI) before radiotherapy, BMI loss during radiotherapy, original tumor site, pathological type, TNM stage, and mean oral cavity irradiated dose. There was a significant difference in the incidence of OM between the two groups (P<0.05). There were fewer patients with severe OM in the intervention group compared to the control group (P<0.05). The onset time of OM in the intervention group was delayed by about 4 days compared to that in the control group (P<0.05). Low-temperature atomization inhalation helped to avoid radiotherapy interruption in the intervention group. No patient in the intervention group suffered any adverse reaction for low-temperature atomization inhalation treatment. Conclusions: Low-temperature atomization inhalation can reduce the incidence and severity of OM, and slow down the progression process of it. It can be used as a new prevention method during radiotherapy, and should be promoted in clinical practice.

2.
Cell Mol Biol Lett ; 24: 10, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30906331

RESUMO

This study was designed to investigate the potential role of microRNA-29c (miR-29c) in biliary atresia-related fibrosis. The expression of miR-29c was determined in 15 pairs of peripheral blood samples from infants with biliary atresia (BA) and infants with non-BA neonatal cholestasis using quantitative real-time PCR. EMT was established by induction with TGF-ß1 in HIBEpiC cells. MiR-29c was inhibited by lipofectamine transfection. The expressions of proteins related to epithelial-mesenchymal transition (EMT), i.e., E-cadherin, N-cadherin and vimentin, were determined using quantitative real-time PCR and western blotting. Direct interaction between miR-29c and DNMT3A and DNMT3B was identified using a luciferase reporter assay. The expressions of DNMT3A and DNMT3B were suppressed by treatment with SGI-1027. Patients with BA showed significantly lower miR-29c levels in peripheral blood samples than the control subjects. In vitro, TGF-ß1-induced EMT significantly decreased the expression of miR-29c. Downregulation of miR-29c had a promotional effect on BA-related fibrosis in HIBEpiC cells, as confirmed by the decrease in E-cadherin and increase in N-cadherin and vimentin levels. MiR-29c was found to target the 3'UTR of DNMT3A and DNMT3B and inhibit their expression. Suppression of DNMT3A and DNMT3B reversed the effects of miR-29c downregulation on BA-related fibrosis in HIBEpiC cells. These data suggest that BA-related fibrosis is closely associated with the occurrence of EMT in HIBEpiC cells. MiR-29c might be a candidate for alleviating BA-related fibrosis by targeting DNMT3A and DNMT3B.


Assuntos
Atresia Biliar/metabolismo , DNA (Citosina-5-)-Metiltransferases/genética , Transição Epitelial-Mesenquimal , Fibrose/metabolismo , MicroRNAs/metabolismo , Atresia Biliar/complicações , Atresia Biliar/fisiopatologia , DNA (Citosina-5-)-Metiltransferases/metabolismo , Fibrose/etiologia , Fibrose/fisiopatologia , Regulação da Expressão Gênica , Humanos , Lactente , MicroRNAs/genética
3.
Bing Du Xue Bao ; 24(6): 421-6, 2008 Nov.
Artigo em Chinês | MEDLINE | ID: mdl-19226949

RESUMO

A monoclonal antibody (8H5), which showed strong neutralization activity against 33 strains of H5N1 viruses isolated from hosts at various regions from 2002 to 2006, was characterized in our lab recently. This result indicated the presence of highly conserved neutralizing site on hemagglutinin (HA) of various H5N1 subtypes. In the present study, the peptide phage display technique was applied to generate mimotope of the conserved neutralizing epitope recognized by 8H5 mAb. Five peptides displayed on phage were identified to specifically bind to 8H5 mAb. One of the five peptides, 123, was further displayed on the virus-like particle assembled from aa 1-149 fragment of HBcAg. The chimeric particle HBc-T123 conserved the specific binding to 8H5 mAb, and competed with H5N1 viruses for 8H5 mAb. The antiserum induced by HBc-T123 intensively stained on SF21 cells infected by recombinant baculovirus containing HA gene of YU22 virus, indicating the production of cross-reactive antibody to H5N1 HA.


Assuntos
Epitopos/imunologia , Glicoproteínas de Hemaglutininação de Vírus da Influenza/imunologia , Virus da Influenza A Subtipo H5N1/imunologia , Influenza Humana/virologia , Sequência de Aminoácidos , Animais , Anticorpos Monoclonais/imunologia , Epitopos/química , Epitopos/genética , Glicoproteínas de Hemaglutininação de Vírus da Influenza/química , Glicoproteínas de Hemaglutininação de Vírus da Influenza/genética , Humanos , Virus da Influenza A Subtipo H5N1/química , Virus da Influenza A Subtipo H5N1/genética , Camundongos , Camundongos Endogâmicos BALB C , Dados de Sequência Molecular , Biblioteca de Peptídeos
4.
Artigo em Chinês | MEDLINE | ID: mdl-16957395

RESUMO

The dynamics of dry and fresh weight, the glucose, fructose, sucrose, titratable acid contents, and activities of sucrose-metabolizing and hexose-metabolizing enzymes were examined in developing fruits of bayberry (Myrica rubra Sieb. et Zucc. cvs. 'Wuzi' and 'Biqi'). The results showed the dry and fresh weight of bayberry fruit increased with fruit development and maturation (Fig. 1), with the highest increase rate of dry matters and water occurring during later stage of fruit development (about 10 d before maturation). The change in titratable acid followed a course of "low-high-low" in developing bayberry fruits (Fig. 3). The titratable acid content reached its peak at about 18 d before fruit maturation, and then decreased rapidly. The sugar compositions in fruits of bayberry cv. 'Wuzi' were different from those in fruits of bayberry cv. 'Biqi'. The main sugar accumulated in fruits of bayberry cv. 'Wuzi' was sucrose, accounting for 2/3 of total sugars but the sucrose content in fruits of bayberry cv. 'Biqi' was below 50% of total sugars. The fructose content in fruits of bayberry cv. 'Wuzi' was 4% higher, but that in fruits of bayberry cv. 'Biqi' was 12% lower than glucose content (Fig. 2). The activities of sucrose cleavage enzymes (invertase and cleavage activity of SS) in the fruit of bayberry cv. 'Biqi' increased with fruit development and maturation, but those activities in fruit bayberry cv. 'Wuzi' were almost stable during fruit development with lower levels of enzyme activities in fruit of cv. 'Wuzi' than in cv. 'Biqi' throughout fruit development (Fig. 4 and Fig. 5A). The SPS activity increased during fruit development (Fig. 6), however, the activity peak of synthetic activity of SS occurred at the middle stage of fruit development (Fig. 5B). The FRK activity in fruit of bayberry cv. 'Wuzi' was higher than that of HXK, but the reverse was in fruit of bayberry cv. 'Biqi' (Fig. 7). These results suggested that the 2-3 weeks before fruit maturation was a key phase for the bayberry development and the formation of fruit quality. There was a correlation between water transport and dry matter accumulation. The different sucrose constitutions between two varieties may be attributed to the differences in the activity levels of the sucrose cleavage enzymes while the difference in the ratio of glucose content to fructose content may be caused by the different activity levels of the hexose-metabolizing enzymes.


Assuntos
Metabolismo dos Carboidratos , Frutas/crescimento & desenvolvimento , Myrica/crescimento & desenvolvimento , Frutas/metabolismo , Hexoses/metabolismo , Myrica/metabolismo , Sacarose/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA